TY - JOUR
T1 - Changes in kidney function after adrenalectomy in patients with primary aldosteronism
AU - Tomiie, Yumi
AU - Hibi, Yatsuka
AU - Nobe, Rie
AU - Yokoi, Keito
AU - Koshima, Yusuke
AU - Ogawa, Kimio
AU - Imai, Tsuneo
AU - Morise, Zenichi
N1 - Publisher Copyright:
© 2025 Yumi Tomiie, MD et al.
PY - 2025
Y1 - 2025
N2 - Objectives: A decrease in the estimated glomerular filtration rate (eGFR) is occasionally observed in patients with primary aldosteronism (PA) after adrenalectomy. Patients may misunderstand that the surgical stress of adrenalectomy can result in kidney dysfunction. However, this finding is considered due to postoperative manifestations of kidney dysfunction that are masked preoperatively by excess aldosterone. To evaluate kidney dysfunction unmasked by adrenalectomy, we investigated changes in the eGFR after adrenalectomy according to the clinically assessable indication of “a certain drop in eGFR” as defined by the 2012 Kidney Disease Improving Global Outcomes clinical practice guideline. Methods: This study included 54 patients with PA who underwent unilateral adrenalectomy between 2005 and 2022 at our institution. We classified patients by GFR categories defined by the guideline according to their pre-and postoperative eGFR. We analyzed the predictors associated with a certain drop in eGFR (i.e., a decrease in GFR category accompanied by a ≥25% decrease in the eGFR from baseline). Results: A certain drop in eGFR was present in 35.2% of patients after adrenalectomy. Multivariate regression analysis showed that a longer duration of hypertension, lower preoperative serum potassium concentrations, and lower serum potassium concentrations before potassium supplementation were significant independent predictors (p<0.05). The cut-off value of the preoperative serum potassium concentrations was 3.7 mmol/L according to receiver operating characteristic curve analysis. Conclusions: Our findings will be useful for surgeons in informing patients with PA regarding the possibility of downgrading GFR categories after adrenalectomy.
AB - Objectives: A decrease in the estimated glomerular filtration rate (eGFR) is occasionally observed in patients with primary aldosteronism (PA) after adrenalectomy. Patients may misunderstand that the surgical stress of adrenalectomy can result in kidney dysfunction. However, this finding is considered due to postoperative manifestations of kidney dysfunction that are masked preoperatively by excess aldosterone. To evaluate kidney dysfunction unmasked by adrenalectomy, we investigated changes in the eGFR after adrenalectomy according to the clinically assessable indication of “a certain drop in eGFR” as defined by the 2012 Kidney Disease Improving Global Outcomes clinical practice guideline. Methods: This study included 54 patients with PA who underwent unilateral adrenalectomy between 2005 and 2022 at our institution. We classified patients by GFR categories defined by the guideline according to their pre-and postoperative eGFR. We analyzed the predictors associated with a certain drop in eGFR (i.e., a decrease in GFR category accompanied by a ≥25% decrease in the eGFR from baseline). Results: A certain drop in eGFR was present in 35.2% of patients after adrenalectomy. Multivariate regression analysis showed that a longer duration of hypertension, lower preoperative serum potassium concentrations, and lower serum potassium concentrations before potassium supplementation were significant independent predictors (p<0.05). The cut-off value of the preoperative serum potassium concentrations was 3.7 mmol/L according to receiver operating characteristic curve analysis. Conclusions: Our findings will be useful for surgeons in informing patients with PA regarding the possibility of downgrading GFR categories after adrenalectomy.
KW - Adrenalectomy
KW - Estimated glomerular filtration rate
KW - Hypokalemia
KW - Kidney dysfunction
KW - Primary aldosteronism
UR - http://www.scopus.com/inward/record.url?scp=85217488316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217488316&partnerID=8YFLogxK
U2 - 10.20407/fmj.2024-011
DO - 10.20407/fmj.2024-011
M3 - Article
AN - SCOPUS:85217488316
SN - 2189-7247
VL - 11
SP - 28
EP - 35
JO - Fujita Medical Journal
JF - Fujita Medical Journal
IS - 1
ER -